These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The mechanism of action of aspirin. Vane JR; Botting RM Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543 [TBL] [Abstract][Full Text] [Related]
6. Does the timing of aspirin administration influence its antiplatelet effect - review of literature on chronotherapy. Miciak-Ławicka E; Begier-Krasińska B; Tykarski A; Krasiński Z Kardiochir Torakochirurgia Pol; 2018 Jun; 15(2):125-129. PubMed ID: 30069194 [TBL] [Abstract][Full Text] [Related]
7. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-kappaB and other unidentified targets. Terracciano S; Aquino M; Rodriquez M; Monti MC; Casapullo A; Riccio R; Gomez-Paloma L Curr Med Chem; 2006; 13(16):1947-69. PubMed ID: 16842204 [TBL] [Abstract][Full Text] [Related]
8. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Schrör K Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351 [TBL] [Abstract][Full Text] [Related]
9. Sir John Robert Vane: 29 March 1927 - 19 November 2004. Moncada S Biogr Mem Fellows R Soc; 2006; 52():401-11. PubMed ID: 18551797 [TBL] [Abstract][Full Text] [Related]
10. [Aspirin throughout the ages: a historical review]. Lévesque H; Lafont O Rev Med Interne; 2000 Mar; 21 Suppl 1():8s-17s. PubMed ID: 10763200 [TBL] [Abstract][Full Text] [Related]
11. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? Ahmed A J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028 [TBL] [Abstract][Full Text] [Related]
12. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485 [TBL] [Abstract][Full Text] [Related]
13. John Robert Vane--British pharmacologist and Nobel laureate. Shampo MA; Kyle RA; Steensma DP Mayo Clin Proc; 2013 Jul; 88(7):e71. PubMed ID: 23809324 [No Abstract] [Full Text] [Related]
14. Effects of cyclooxygenase inhibition on endothelial function in hypertensive patients treated with angiotensin-converting enzyme inhibitors. Yamanari H; Nakamura K; Kakishita M; Ohe T Clin Cardiol; 2004 Sep; 27(9):523-7. PubMed ID: 15471166 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins in action indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions. Wong SL; Wong WT; Tian XY; Lau CW; Huang Y Adv Pharmacol; 2010; 60():61-83. PubMed ID: 21081215 [TBL] [Abstract][Full Text] [Related]
17. Special issue in honour of Sir John Vane, F.R.S., Nobel Laureate, the discoverer of the mechanism of action of aspirin. Proceedings of the Jagiellonian Medical Research Center Club Meeting, Krakow, Poland, 31 May-3 June 2003. Thromb Res; 2003 Jun; 110(5-6):253-369. PubMed ID: 14592542 [No Abstract] [Full Text] [Related]
18. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736 [TBL] [Abstract][Full Text] [Related]
19. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152 [TBL] [Abstract][Full Text] [Related]
20. Prostacyclin release and the modulation of some vasoactive hormones. Mullane KM; Moncada S Prostaglandins; 1980 Jul; 20(1):25-49. PubMed ID: 6996037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]